scispace - formally typeset
X

Xiaowan Chen

Researcher at China Medical University (PRC)

Publications -  67
Citations -  2184

Xiaowan Chen is an academic researcher from China Medical University (PRC). The author has contributed to research in topics: Cancer & Colorectal cancer. The author has an hindex of 24, co-authored 66 publications receiving 1624 citations. Previous affiliations of Xiaowan Chen include Chinese Ministry of Education.

Papers
More filters
Journal ArticleDOI

Non-coding RNAs participate in the regulatory network of CLDN4 via ceRNA mediated miRNA evasion

TL;DR: A regulatory network in gastric cancer is revealed whereby claudin-4 expression is reduced by specific miRNAs, which are in turn bound by specific lncRNAs acting as competing endogenous RNAs (ceRNAs), resulting in increased claudIn-4expression.
Journal ArticleDOI

The prognostic nutritional index is a predictive indicator of prognosis and postoperative complications in gastric cancer: A meta-analysis

TL;DR: PNI was a predictive indicator of survival and postoperative complications, and was associated with clinicopathological features in GC patients, however, a low PNI was not significantly associated with poor OS in patients with GC at stage IV.
Journal ArticleDOI

Meta-analysis of the prognostic value of circulating tumor cells detected with the CellSearch System in colorectal cancer

TL;DR: A meta-analysis indicates that the detection of CTCs in the peripheral blood with the CellSearch System has prognostic utility for patients with CRC.
Journal ArticleDOI

Clinical significance of palliative gastrectomy on the survival of patients with incurable advanced gastric cancer: a systematic review and meta-analysis

TL;DR: From the results of the meta-analysis, palliative gastrectomy for patients with incurable advanced gastric cancer may be associated with longer survival, especially for Patients with stage M1 Gastric cancer.
Journal ArticleDOI

Benefits of hyperthermic intraperitoneal chemotherapy for patients with serosal invasion in gastric cancer: a meta-analysis of the randomized controlled trials.

TL;DR: It is demonstrated that HIPC may improve the overall survival rate for patients who receive resection for advance Gastric cancer potentially, and help to prevent peritoneal local recurrence among patients with serosal invasion in gastric cancer.